Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids

J Am Soc Nephrol. 2020 Jul;31(7):1445-1461. doi: 10.1681/ASN.2019080852. Epub 2020 Jun 1.

Abstract

Background: Short-chain fatty acids derived from gut microbial fermentation of dietary fiber have been shown to suppress autoimmunity through mechanisms that include enhanced regulation by T regulatory cells (Tregs).

Methods: Using a murine kidney transplantation model, we examined the effects on alloimmunity of a high-fiber diet or supplementation with the short-chain fatty acid acetate. Kidney transplants were performed from BALB/c(H2d) to B6(H2b) mice as allografts in wild-type and recipient mice lacking the G protein-coupled receptor GPR43 (the metabolite-sensing receptor of acetate). Allograft mice received normal chow, a high-fiber diet, or normal chow supplemented with sodium acetate. We assessed rejection at days 14 (acute) and 100 (chronic), and used 16S rRNA sequencing to determine gut microbiota composition pretransplantation and post-transplantation.

Results: Wild-type mice fed normal chow exhibited dysbiosis after receiving a kidney allograft but not an isograft, despite the avoidance of antibiotics and immunosuppression for the latter. A high-fiber diet prevented dysbiosis in allograft recipients, who demonstrated prolonged survival and reduced evidence of rejection compared with mice fed normal chow. Allograft mice receiving supplemental sodium acetate exhibited similar protection from rejection, and subsequently demonstrated donor-specific tolerance. Depletion of CD25+ Tregs or absence of the short-chain fatty acid receptor GPR43 abolished this survival advantage.

Conclusions: Manipulation of the microbiome by a high-fiber diet or supplementation with sodium acetate modified alloimmunity in a kidney transplant model, generating tolerance dependent on Tregs and GPR43. Diet-based therapy to induce changes in the gut microbiome can alter systemic alloimmunity in mice, in part through the production of short-chain fatty acids leading to Treg cell development, and merits study as a potential clinical strategy to facilitate transplant acceptance.

Keywords: acute allograft rejection; chronic allograft rejection; immunology; tolerance; transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Allografts / immunology
  • Animals
  • Butyric Acid / pharmacology
  • Chronic Disease
  • Dietary Fiber / administration & dosage*
  • Dietary Supplements
  • Dysbiosis / etiology
  • Dysbiosis / microbiology
  • Dysbiosis / prevention & control
  • Fatty Acids, Volatile / immunology*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / immunology*
  • Graft Rejection / pathology
  • Graft Rejection / physiopathology
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects
  • Graft Survival / immunology
  • Immune Tolerance / drug effects*
  • Kidney Transplantation / adverse effects
  • Lymphocyte Activation
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, G-Protein-Coupled / genetics
  • Sodium Acetate / pharmacology
  • T-Lymphocytes, Regulatory*

Substances

  • Dietary Fiber
  • Fatty Acids, Volatile
  • Ffar2 protein, mouse
  • Receptors, G-Protein-Coupled
  • Butyric Acid
  • Sodium Acetate